HOLOGIC INC Forms 3, 4 and 5: Restricted Stock Units and Performance Rights
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 48 rows in 2016. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2016-12-06: Reporting owner MACMILLAN STEPHEN P; Form 4; Security Restricted Stock Unit Award (Right To Receive); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2016-12-06: Reporting owner MACMILLAN STEPHEN P; Form 4; Security Restricted Stock Unit Award (Right To Receive); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2016-12-06: Reporting owner MACMILLAN STEPHEN P; Form 4; Security Performance Stock Unit Award (Right to Receive); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2016-12-06: Reporting owner MACMILLAN STEPHEN P; Form 4; Security Performance Stock Unit Award (Right to Receive); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2016-12-06 | MACMILLAN STEPHEN P Director, Officer (Chairman, President and CEO) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −19,628 19,628 owned after | no price filed | 2016-12-08 | |
| 2016-12-06 | MACMILLAN STEPHEN P Director, Officer (Chairman, President and CEO) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −28,039 28,040 owned after | no price filed | 2016-12-08 | |
| 2016-12-06 | MACMILLAN STEPHEN P Director, Officer (Chairman, President and CEO) | 4 | Performance Stock Unit Award (Right to Receive) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +150,739 307,760 owned after | no price filed | 2016-12-08 | |
| 2016-12-06 | MACMILLAN STEPHEN P Director, Officer (Chairman, President and CEO) | 4 | Performance Stock Unit Award (Right to Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −307,760 0 owned after | no price filed | 2016-12-08 | |
| 2016-11-18 | Oberton Karleen Marie Officer (Corp. VP & Chief Acctg Officer) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,195 0 owned after | no price filed | 2016-11-22 | |
| 2016-11-18 | Oberton Karleen Marie Officer (Corp. VP & Chief Acctg Officer) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,515 1,515 owned after | no price filed | 2016-11-22 | |
| 2016-11-14 | Oberton Karleen Marie Officer (Corp. VP & Chief Acctg Officer) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,794 0 owned after | no price filed | 2016-11-16 | |
| 2016-11-07 | Compton Eric B. Officer (COO) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,636 7,273 owned after | no price filed | 2016-12-05 | |
| 2016-11-07 | Valenti Peter J. III Officer (Division Pres., Breast Health) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,908 3,815 owned after | no price filed | 2016-11-08 | |
| 2016-11-07 | MACMILLAN STEPHEN P Director, Officer (Chairman, President and CEO) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −17,348 34,696 owned after | no price filed | 2016-11-08 | |
| 2016-11-07 | McMahon Robert W. Officer (Chief Financial Officer) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,577 7,154 owned after | no price filed | 2016-11-08 | |
| 2016-11-07 | Oberton Karleen Marie Officer (Corp. VP & Chief Acctg Officer) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,860 3,720 owned after | no price filed | 2016-11-08 | |
| 2016-11-05 | MACMILLAN STEPHEN P Director, Officer (Chairman, President and CEO) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −15,119 30,238 owned after | no price filed | 2016-12-05 | |
| 2016-11-05 | West Thomas A. Officer (Div President & GM, Diagnostic) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,085 4,171 owned after | no price filed | 2016-12-05 | |
| 2016-11-05 | Valenti Peter J. III Officer (Division Pres., Breast Health) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,085 4,171 owned after | no price filed | 2016-12-05 | |
| 2016-11-05 | Griffin John M. Officer (General Counsel) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,502 5,005 owned after | no price filed | 2016-12-05 | |
| 2016-11-04 | Compton Eric B. Officer (COO) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,128 6,256 owned after | no price filed | 2016-11-08 | |
| 2016-11-04 | McMahon Robert W. Officer (Chief Financial Officer) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,303 6,707 owned after | no price filed | 2016-11-08 | |
| 2016-11-04 | Oberton Karleen Marie Officer (Corp. VP & Chief Acctg Officer) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −774 1,572 owned after | no price filed | 2016-11-08 | |
| 2016-10-03 | West Thomas A. Officer (Div President & GM, Diagnostic) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,063 8,127 owned after | no price filed | 2016-10-04 | |
| 2016-06-17 | ULLIAN ELAINE Director | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −401 0 owned after | no price filed | 2016-06-21 | |
| 2016-05-26 | Oberton Karleen Marie Officer (Corp. VP & Chief Acctg Officer) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −525 1,050 owned after | no price filed | 2016-05-31 | |
| 2016-05-26 | Valenti Peter J. III Officer (Division Pres., Breast Health) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,411 6,822 owned after | $23.82 exercise price | 2016-05-31 | |
| 2016-05-26 | McMahon Robert W. Officer (Chief Financial Officer) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,347 14,694 owned after | no price filed | 2016-05-31 | |
| 2016-04-14 | Compton Eric B. Officer (COO) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,189 8,377 owned after | no price filed | 2016-04-18 | |
| 2016-03-07 | McMahon Robert W. Officer (Chief Financial Officer) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +2,155 2,155 owned after | $0.00 | 2016-03-09 | |
| 2016-03-07 | Compton Eric B. Officer (COO) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,592 3,592 owned after | $0.00 | 2016-03-09 | |
| 2016-03-02 | COUGHLIN CHRISTOPHER J Director | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +2,427 2,427 owned after | $0.00 | 2016-03-04 | |
| 2016-03-02 | MERKSAMER SAMUEL J. Director | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +2,427 2,427 owned after | $0.00 | 2016-03-04 | |
| 2016-03-02 | CHRISTODORO JONATHAN Director | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +2,427 2,427 owned after | $0.00 | 2016-03-04 | |
| 2016-03-02 | ULLIAN ELAINE Director | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,260 3,260 owned after | $0.00 | 2016-03-04 | |
| 2016-03-02 | Stamoulis Christiana Director | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +2,427 2,427 owned after | $0.00 | 2016-03-04 | |
| 2016-03-02 | Levy Lawrence M Director | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +2,427 2,427 owned after | $0.00 | 2016-03-04 | |
| 2016-03-02 | LEAMING NANCY Director | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +2,427 2,427 owned after | $0.00 | 2016-03-04 | |
| 2016-03-02 | GARRETT SCOTT T Director | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +2,427 2,427 owned after | $0.00 | 2016-03-04 | |
| 2016-03-02 | CRAWFORD SALLY Director | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +2,427 2,427 owned after | $0.00 | 2016-03-04 | |
| 2016-02-02 | Griffin John M. Officer (General Counsel) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,033 3,099 owned after | no price filed | 2016-02-04 | |
| 2016-02-02 | Griffin John M. Officer (General Counsel) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,342 4,029 owned after | no price filed | 2016-02-04 | |
| 2016-01-01 | GARRETT SCOTT T Director | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,272 0 owned after | no price filed | 2016-01-05 | |
| 2016-01-01 | MERKSAMER SAMUEL J. Director | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,272 0 owned after | no price filed | 2016-01-05 | |
| 2016-01-01 | ULLIAN ELAINE Director | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,272 0 owned after | no price filed | 2016-01-05 | |
| 2016-01-01 | CRAWFORD SALLY Director | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,272 0 owned after | no price filed | 2016-01-05 | |
| 2016-01-01 | Stamoulis Christiana Director | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,272 0 owned after | no price filed | 2016-01-05 | |
| 2016-01-01 | LEAMING NANCY Director | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,272 0 owned after | no price filed | 2016-01-05 | |
| 2016-01-01 | CHRISTODORO JONATHAN Director | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,272 0 owned after | no price filed | 2016-01-05 | |
| 2016-01-01 | Levy Lawrence M Director | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,272 0 owned after | no price filed | 2016-01-05 | |
| 2016-01-01 | LAVANCE DAVID R JR Director | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,207 0 owned after | no price filed | 2016-01-05 | |
| 2016-01-01 | WILSON WAYNE Director | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,272 0 owned after | no price filed | 2016-01-05 |